SALIOGEN THERAPEUTICS
Startup
SALIOGEN THERAPEUTICS
Description
SalioGen Therapeutics develops Gene Coding - a new category of genetic medicine designed for adding a new genomic code to turn on, off or modify the functions of new or existing genes.
Resources
SALIOGEN THERAPEUTICS
Address
245 FIRST STREET, 18TH FLOOR , CAMBRIDGE MASSACHUSETTS 02142 UNITED STATES
United States
United States
Contact
info@saliogen.com
Description
SalioGen Therapeutics develops Gene Coding - a new category of genetic medicine designed for adding a new genomic code to turn on, off or modify the functions of new or existing genes.
Resources
Matchmaking
Connect with SALIOGEN THERAPEUTICS
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways